Correlation Between Zentalis Pharmaceuticals and Cognition Therapeutics

Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Cognition Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Cognition Therapeutics.

Diversification Opportunities for Zentalis Pharmaceuticals and Cognition Therapeutics

0.26

Correlation Coefficient

Zentalis Pharmaceuticals  Cognition Therapeutics

Modest diversification

The 3 months correlation between Zentalis and Cognition is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Cognition Therapeutics go up and down completely randomly.

Pair Corralation between Zentalis Pharmaceuticals and Cognition Therapeutics

Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to generate 0.87 times more return on investment than Cognition Therapeutics. However, Zentalis Pharmaceuticals Llc is 1.15 times less risky than Cognition Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Cognition Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  368.00  in Zentalis Pharmaceuticals Llc on September 16, 2024 and sell it today you would lose (59.00) from holding Zentalis Pharmaceuticals Llc or give up 16.03% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Zentalis Pharmaceuticals Llc  vs.  Cognition Therapeutics

Zentalis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zentalis Pharmaceuticals Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Cognition Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Zentalis Pharmaceuticals and Cognition Therapeutics

The main advantage of trading using opposite Zentalis Pharmaceuticals and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.

The idea behind Zentalis Pharmaceuticals Llc and Cognition Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.